bicalutamide 50 mg film-coated tablets
lexon pharmaceuticals (ireland) limited - bicalutamide - film-coated tablet - 50 milligram(s) - anti-androgens; bicalutamide
mpl-bicalutamide bicalutamide 50mg film-coated tablet blister pack
mundipharma pty ltd - bicalutamide, quantity: 50 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; povidone; sodium starch glycollate type a; titanium dioxide; hypromellose; macrogol 400 - treatment of advanced prostate cancer in combination with lhrh agonist therapy.
bicalutamide tablet
sorres pharma inc - bicalutamide - tablet - 50mg - bicalutamide 50mg - antineoplastic agents
bicalutamide 50mg film-coated tablets
fresenius kabi oncology plc - bicalutamide - film-coated tablet - 50 milligram(s) - anti-androgens; bicalutamide
bicalutamide 50mg film-coated tablets
accord healthcare limited - bicalutamide - film-coated tablet - 50 milligram(s) - anti-androgens; bicalutamide
bicalutamide 50mg film-coated tablets
fresenius kabi deutschland gmbh - bicalutamide - film-coated tablet - 50 milligram(s) - anti-androgens; bicalutamide
bicalutamide 50 mg film-coated tablets
accord healthcare ireland ltd. - bicalutamide - film-coated tablet - 50 milligram(s) - anti-androgens; bicalutamide
bicalutamide 150 mg film-coated tablets
fresenius kabi oncology plc - bicalutamide - film-coated tablet - 150 milligram(s) - anti-androgens; bicalutamide
bicalutamide 150 mg film-coated tablets
fresenius kabi deutschland gmbh - bicalutamide - film-coated tablet - 150 milligram(s) - anti-androgens; bicalutamide
bicalutamide
dr reddy's new zealand limited - bicalutamide 50mg - film coated tablet - 50 mg - active: bicalutamide 50mg excipient: acetone crospovidone hypromellose isopropyl alcohol lactose monohydrate magnesium stearate microcrystalline cellulose opadry white oy-58900 purified water sodium laurilsulfate - treatment of advanced prostate cancer in combination with gnrh (lhrh) agonist therapy or surgical castration. prevention of disease flare associated with the use of lhrh agonists.